This pilot clinical trial studies mechanical stimulation in preventing bone density loss in patients undergoing donor stem cell transplant. Mechanical stimulation may limit, prevent, or reverse bone loss, increase muscle and cardiac performance, and improve overall health
PRIMARY OBJECTIVES: I. To determine the feasibility of a mechanical stimulation regimen in hematopoietic cell transplant (HCT) patients. SECONDARY OBJECTIVES: I. To evaluate the data collection tools to prepare for a larger phase II trial. OUTLINE: Patients undergo mechanical stimulation over 20 minutes once daily (QD) beginning on date of hospital admission and continuing through day 100 post-HCT, except for day 0 (date of transplant).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Undergo mechanical stimulation
Undergo mechanical stimulation
Refinement of mechanical stimulation protocol
Best time of day for treatment, staff involvement, etc.
Time frame: From hospital admission to 100 days post-HCT
Adherence with treatment
Time frame: From hospital admission to 100 days post-HCT
Effective data collection tools and data points
Time frame: From hospital admission to 100 days post-HCT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.